Filter Results:
(142)
Show Results For
- All HBS Web
(142)
- News (58)
- Research (67)
- Multimedia (3)
- Faculty Publications (24)
Show Results For
- All HBS Web
(142)
- News (58)
- Research (67)
- Multimedia (3)
- Faculty Publications (24)
- 08 Nov 2021
- Blog Post
4 Ways the MS/MBA is Preparing Me for a Career in Health Care and the Life Sciences
The Hebrew University of Jerusalem, focusing on neuroscience. There I was part of two academic labs, one focusing on the impact of stress on the immune system, and the other on translational bioengineering. Looking at my long-term goals,... View Details
- 15 Mar 2017
- Lessons from the Classroom
More Than 900 Examples of How Climate Change Affects Business
This word cloud is composed of blog posts by more than 900 students describing how individual organizations are likely to be affected by climate change. Image by Patrick Clapp Last fall, first-year MBA students at Harvard Business School received a new assignment in... View Details
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- 09 Dec 2002
- Research & Ideas
Most Accountants Aren’t Crooks—Why Good Audits Go Bad
bias and moderate its ill effects. Only then can we be assured of the reliability of the financial reports issued by public companies and ratified by professional accountants. Professional accountants might seem immune to such biases... View Details
- 23 Jan 2013
- Research & Ideas
Three-Dimensional Strategy: Winning the Multisided Platform
becomes more attractive. When a product doesn't work out, the buck all too often stops with the reseller, not the supplier; an MSP is immune to this risk. Different issues come into play in the decision to be either an input supplier or... View Details
Keywords: by Julia Hanna
- 11 Mar 2021
- News
Leading with Heart
early in our marriage, we lost our first daughter. She was just eight months old. Her name was Tanya. She was born with an immune disease that had no cure. And that was a very hard thing to comprehend and cope with. And then we had... View Details
- 27 Feb 2024
- Blog Post
Fighting Cancer with a Novel Cell Therapy: Ananya Zutshi (MS/MBA '21)
and will call myself an engineer forever. But I recognized that my strengths and experiences are well suited for the business side of drug development.” Guardian Bio’s cell therapy uses dendritic cells, an essential component in the human View Details
Paul C. Henshaw
A geologist by training, Henshaw was not immune to being on the frontline of mine exploration and development. Through his efforts, Homestake became an established provider of uranium. In addition, he personally was responsible for... View Details
Keywords: Agriculture & Mining
- 24 Apr 2014
- News
Offering a breath of life for critically ill patients
Technology, which manufactures the synthetic scaffolds and bioreactors used to seed the patient’s own bone marrow cells on the scaffold prior to transplant. The cells quickly grow a new trachea, which, because it is made from the patient’s own cells, is not rejected by... View Details
- Web
2023 Symposium - Race, Gender & Equity
Yuille presents "Love, Pain, & the Rules of the Game" Panel: Black Feminist Perspectives on Rage and Love Panel: Buddhist Perspectives on Rage and Love A Tool For Humanity - Immunity to Change Workshop Lisa Lahey facilitates "A Tool for... View Details
- 18 Jul 2024
- Blog Post
Harvard Business School Announces Its 2024-2025 Blavatnik Fellows
immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat cancer and neurodegenerative disorders, and AI-driven medical... View Details
- 01 Oct 2001
- News
Finding Their Way
The best-laid plans — even those designed and implemented by the remarkably talented alumni of HBS — are seldom immune to life's twists and turns. This is perhaps the overriding lesson that each member of the Class of 1976 has learned... View Details
Keywords: Management
- 01 Aug 2013
- News
A Cure for Cold Storage
Michael Schrader The measles, says Vaxess CEO Michael Schrader (MBA 2012), is the perfect example of what's wrong with the modern vaccine. Despite the fact that a measles immunization has been available for more than 40 years, there are... View Details
- Portrait Project
Meghan Murray
incomplete vanished. My mind became immune to the electrical impulses to stop and grimace, And I made my beats heard in spite of the pain. I don’t remember whether I stood on the podium that day, But I do remember the pride in surprising... View Details
- 01 Jun 2018
- News
Floor It
The sci-fi future for cancer treatment has become a reality, with breakthrough therapies that can use a cancer patient’s genetic information to create personalized treatments or employ the body’s immune response to treat disease. But for... View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
therapies has become a reality, as have immunotherapies that induce or suppress a body’s immune response to treat disease. Yet, this relatively swift progress has not been fast enough for millions of other patients who still lack... View Details
- 01 Mar 2005
- News
Better Care at Lower Cost
The U.S. health-care industry isn’t immune to the forces of disruptive innovation that already have transformed other businesses, from computer manufacturing to retailing, HBS professor Clayton M. Christensen told 250 participants at the... View Details
- 01 Sep 2003
- News
Mark Fuller
was not immune to the effects of recent worldwide economic sluggishness. “We had some sobering moments in 2001 and 2002,” admits Fuller. But grappling with slower growth “made everyone a lot smarter.” After twenty years at the helm,... View Details
- 25 Apr 2014
- Research & Ideas
To Pay or Not to Pay: Argentina and the International Debt Market
recalcitrant" negotiating strategy. Until the 1970s, the act of lending to a foreign country was little more than "an act of faith," as economic advisor Herbert Feis said in 1930. Given that sovereign immunity prevented... View Details
Keywords: by Laura Alfaro
- 01 Sep 2012
- News
Rebel with a Cause
introduced HIV and hepatitis C into his system. Today he’s in full health: a liver transplant cured both the hemophilia and the hepatitis, and tests showed he is naturally immune to HIV infection. This past March Massie was named... View Details